谷红注射液联合依达拉奉治疗脑梗死后血管性痴呆的疗效观察

Curative effects of the Guhong injection plus edaravone on vascular dementia after cerebral infarction

目的:对谷红注射液联合依达拉奉治疗脑梗死后血管性痴呆的临床效果进行系统分析。方法:以我院收治的68例脑梗死后血管性痴呆患者作为研究对象,根据临床治疗方法的差异分成实验组和对比组,每组34例;对比组患者在常规治疗基础上应用依达拉奉治疗,实验组则在对比组基础上联用谷红注射液治疗,均治疗3周,对两组临床效果进行评价和分析。结果:治疗后,两组患者的MMSE评分和ADL评分均得到改善,实验组优于对比组,差异显著,有统计意义(P<0.05);两组均未出现明显不良反应(P>0.05)。结论:在脑梗死后血管性痴呆治疗中,应用谷红注射液联合依达拉奉的临床效果确切,可有效改善患者病症,提高患者的生活质量,安全性较高,值得临床应用。

Objective: To analyze the clinical effect of the Guhong injection plus edaravone on vascular dementia after cerebral infarction. Methods: 68 patients were randomly divided into the experimental group and control group. The experimental group was treated with the Guhong injection plus edaravone, for 3 weeks. Results: After treatment, MMSE and ADL in the experimental group were better than the control group (P<0.05). Conclusion: For ascular dementia after cerebral infarction patients, the Guhong injection plus edaravone can improve the quality of life.